Japanese sushi chain investigated for obtaining rival chain s internal sales data seafoodsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seafoodsource.com Daily Mail and Mail on Sunday newspapers.
Carlyle, Brighton Park invest $200 million in drug development firm Indegene
The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company
PB Jayakumar | February 4, 2021 | Updated 00:25 IST
Global private equity fund Carlyle and US-based Brighton Park Capital have acquired an undisclosed minority stake in Bengaluru-based drug development services and technology provider Indegene for $200 million (Rs 1,461 crore).
The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company.
Indegene offers its customers design, build, and manage operations that leverage data and automation to accelerate clinical development and regulatory compliance in biopharma industry. The company claims to have 18 of the top 20 global biopharma organisations as its customer
This press release was orginally distributed by SBWire
Edison, NJ (SBWIRE) 12/28/2020 Sushi Restaurants Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Sushi Restaurants industry with an attention on the Global market. The report gives key insights available status of the Sushi Restaurants producers and is an important wellspring of direction and course for organizations and people keen on the business. By and large, the report gives an inside and out understanding of 2020-2025 worldwide Sushi Restaurants Market covering extremely significant parameters.
Key Players in This Report Include,